Top Healthcare Stocks Losers today are BCRX, ABIO, SNTA

To Subscribe to our free online Stock market updates ,you can visit our website : http://www.pennystockpickreport.com/

BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) plunges 4.67% to $8.27. The stock hit an intraday high and an intraday low of $8.41 and $8.17 respectively. In the last six months the stock went up over 80%. BioCryst Pharmaceuticals, Inc. is a biotechnology company that designs, optimizes and develops drugs that block enzymes involved in cancer, viral infections and autoimmune diseases. BioCryst integrates the necessary disciplines of biology, crystallography, medicinal chemistry and computer modeling to use structure-based drug design to discover and develop small molecule pharmaceuticals.

ARCA biopharma, Inc. (NASDAQ:ABIO) plunges 8.54% to $3. The stock hit an intraday high and an intraday low of $3.17 and $2.96 respectively. In the last six months the stock went down over 68%. ARCA biopharma, Inc. formerly Nuvelo, Inc. is a biopharmaceutical company focused on developing genetically-targeted therapies for heart failure and other cardiovascular diseases.

Synta Pharmaceuticals Corp. (NASDAQ:SNTA) plunges 11.25% to $3.90. The stock hit an intraday high and an intraday low of $4.29 and $3.77 respectively. In the last six months the stock went down over 19%. Synta Pharmaceuticals Corp. is a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to extend and enhance the lives of patients with severe medical conditions, including cancer and chronic inflammatory diseases.

ABOUT PennyStockPickReport.com

 Penny Stock Pick Report is an independent electronic publication that provides information on selected publicly traded companies. Penny Stock Pick Report is not a registered investment advisor or broker-dealer. Penny Stock Pick Report affiliates, directors, officers, and employees may purchase and sell additional shares in any company which are mentioned above and may profit in the event those shares rise in value. Please do your research before you plan to invest in any of the stocks mentioned above.